Crescent Grove Advisors, LLC Eli Lilly & CO Transaction History

Crescent Grove Advisors, LLC

$931 Million
Q1 2024

A detailed history of Crescent Grove Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 2,894 shares of LLY stock, worth $2.6 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,894

Previous 2,994 3.34%

Holding current value

$2.6 Million

Previous $1.75 Million 29.0%

% of portfolio

0.24%

Previous 0.2%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $59,220 - $79,228	-100 Reduced 3.34%	2,894 $2.25 Million
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $10,503 - $12,382	-20 Reduced 0.66%	2,994 $1.75 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $27,820 - $38,355	64 Added 2.17%	3,014 $1.62 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $10,171 - $13,600	-29 Reduced 0.97%	2,950 $1.38 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $31,063 - $36,482	100 Added 3.47%	2,979 $1.02 Million

Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $9,324 - $10,865	29 Added 1.02%	2,879 $0
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $16,306 - $18,582	-55 Reduced 1.89%	2,850 $922,000
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $16,662 - $20,707	71 Added 2.51%	2,905 $832,000
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $56,212 - $69,760	250 Added 9.67%	2,834 $783,000
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $55,248 - $71,463	-306 Reduced 10.59%	2,584 $593,000
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $32,864 - $42,544	200 Added 7.43%	2,890 $540,000
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $7,503 - $9,029	55 Added 2.09%	2,690 $442,000
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $22,976 - $28,438	-193 Reduced 6.82%	2,635 $366,000
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $53,460 - $66,215	500 Added 21.48%	2,828 $372,000
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $6,647 - $7,759	-60 Reduced 2.51%	2,328 $258,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $19,034 - $22,404	-171 Reduced 6.68%	2,388 $310,000
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $44,901 - $50,303	424 Added 19.86%	2,559 $296,000
Q3 2018 Nov 05, 2018	BUY	$85.86 - $107.31 $183,311 - $229,106	2,135 New	2,135 $229,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.

Account

Crescent Grove Advisors, LLC Eli Lilly & CO Transaction History